Accent Therapeutics
Latest round
- Series C
Last raised
- Jan 2024
Total raised
- $111M
Investors
- 13
About Accent Therapeutics
Based in Massachusetts, US, and founded in 2017 by Robert A.a. Accent Therapeutics operates as a biotechnology company that develops oncology-focused therapies using epi transcriptomics. The therapy modifies the chemical composition of RNA cells to regulate proteins that focus on cellular growth and differentiation. In January 2024, Accent Therapeutics, Inc.85 million post-money. Accent Therapeutics develops small-molecule therapies targeting RNA-modifying proteins (RMPs) to treat various cancers. The company’s platform leverages expertise in cancer biology to identify and inhibit intracellular enzyme targets, focusing on critical areas for drug discovery. The company's pipeline includes first-in-class and best-in-class programs designed to address significant unmet medical needs. The firm’s approach prioritizes biomarker-driven oncology indications, aiming to generate new investigational new drugs (INDs) every 12–18 months.
Who invested in Accent Therapeutics
13 investors across 3 rounds
See all investors in Accent Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Accent Therapeutics
Who invested in Accent Therapeutics?
Accent Therapeutics has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accent Therapeutics raised?
Accent Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Accent Therapeutics last raise money?
Accent Therapeutics's most recent round on record is a Series C, in Jan 2024.
What does Accent Therapeutics do?
Based in Massachusetts, US, and founded in 2017 by Robert A.
Where is Accent Therapeutics headquartered?
Accent Therapeutics is headquartered in Lexington, US.
Which VCs invest in companies like Accent Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Accent Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Accent Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.